X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Cadila Healthcare Fact Sheet, Cadila Healthcare Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Cadila Healthcare Fact Sheet   (CADIL)

Here is the latest financial fact sheet of Cadila Healthcare. For more details, see the Cadila Healthcare quarterly results and Cadila Healthcare share price and chart. For a sector overview, read our pharmaceuticals sector report.

CADILA HEALTHCARE Price History

Price Rs 380.8
Mkt Cap Rs m 389,789
Vol '000 87.1
P/E X 18.8
P/CF X 16.9
EPS (TTM) Rs 20.2
% ch % -0.6
No. of shares m 1,023.74
% ch week % 0.2
% ch 1-mth % -7.8
% ch 12-mth % -23.9
52 week H/L Rs 515.0/332.9
(As on Oct 16, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

CADILA HEALTHCARE Financials

No. of Mths
Year Ending
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
CADILA HEALTHCARE EQUITY SHARE DATA
High Rs1,0791,763454460558 
Low Rs631872305305362 
Sales per share (Unadj.) Rs352.8422.592.191.6116.3 
Earnings per share (Unadj.) Rs39.256.219.214.817.9 
Diluted earnings per shareRs7.811.219.214.817.9 
Cash flow per share (Unadj.) Rs49.170.222.018.523.1 
Dividends per share (Unadj.) Rs9.0012.003.203.203.50 
Adj. dividends per shareRs1.802.403.203.203.50 
Dividend yield (eoy) %1.10.90.80.80.8 
Book value per share (Unadj.) Rs168.0220.855.768.085.4 
Adj. book value per shareRs33.644.255.768.085.4 
Shares outstanding (eoy) m204.75204.751,023.741,023.741,023.74 
Bonus/Rights/Conversions  --FV5:1-- 
Price / Sales ratio x2.43.14.14.24.0 
Avg P/E ratio x21.823.419.825.825.7 
P/CF ratio (eoy) x17.418.817.220.719.9 
Price / Book Value ratio x5.16.06.85.65.4 
Dividend payout %22.921.416.721.619.6 
Avg Mkt Cap Rs m175,061269,758388,458391,581470,664 
No. of employees `00012.213.215.416.911.8 
Total wages/salary Rs m10,71112,08512,61615,19818,545 
Avg. sales/employee Rs Th5,908.26,564.06,105.05,563.010,072.7 
Avg. wages/employee Rs Th876.0916.9817.0901.71,569.1 
Avg. net profit/employee Rs Th657.2873.01,272.1901.51,547.7 
CADILA HEALTHCARE INCOME DATA
Net Sales Rs m72,24086,51394,26893,765119,049 
Other income Rs m5075541,1561,2841,132 
Total revenues Rs m72,74787,06795,42495,049120,181 
Gross profit Rs m12,00117,59923,30519,04428,475 
Depreciation Rs m2,0122,8732,9213,7335,388 
Interest Rs m902679528446911 
Profit before tax Rs m9,59414,60121,01216,14923,308 
Minority Interest Rs m-326-397430338628 
Prior Period Items Rs m26542000 
Extraordinary Inc (Exp) Rs m-172-104-25-30 
Tax Rs m1,3252,6361,7741,2895,644 
Profit after tax Rs m8,03611,50619,64315,19518,292 
Gross profit margin %16.620.324.720.323.9 
Effective tax rate %13.818.18.48.024.2 
Net profit margin %11.113.320.816.215.4 
CADILA HEALTHCARE BALANCE SHEET DATA
Current assets Rs m34,37940,88742,80460,22382,005 
Current liabilities Rs m28,14029,92134,61053,05860,720 
Net working cap to sales %8.612.78.77.617.9 
Current ratio x1.21.41.21.11.4 
Inventory Days Days6960527073 
Debtors Days Days5769688998 
Net fixed assets Rs m40,15340,52646,98772,98483,703 
Share capital Rs m1,0241,0241,0241,0241,024 
"Free" reserves Rs m27,84544,18455,96868,57686,421 
Net worth Rs m34,39045,20856,99269,60087,445 
Long term debt Rs m13,62211,5048,96424,68425,551 
Total assets Rs m79,86591,342105,506152,207180,653 
Interest coverage x11.622.540.837.226.6 
Debt to equity ratio x0.40.30.20.40.3 
Sales to assets ratio x0.90.90.90.60.7 
Return on assets %11.213.319.110.310.6 
Return on equity %23.425.534.521.820.9 
Return on capital %21.426.133.318.022.0 
Exports to sales %27.732.547.200 
Imports to sales %5.86.26.200 
Exports (fob) Rs m20,03828,08044,53700 
Imports (cif) Rs m4,2105,3915,83800 
Fx inflow Rs m20,61329,66644,88121,28042,683 
Fx outflow Rs m6,8648,0939,06910,87411,242 
Net fx Rs m13,74921,57335,81210,40631,441 
CADILA HEALTHCARE CASH FLOW
From Operations Rs m 9,028 9,936 18,935 13,117 9,193 
From Investments Rs m -4,380 -4,647 -8,635 -28,719 -9,737 
From Financial Activity Rs m -5,287 -3,511 -9,348 23,158 515 
Net Cashflow Rs m -639 1,778 991 7,556 -29 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 74.8%
Foreign collaborators 0.0%
Indian inst/Mut Fund 8.3%
FIIs 5.9%
ADR/GDR 0.0%
Free float 11.0%
Shareholders 44,069
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Zydus Tower, Satellite Cross Roads, Ahmedabad - 380 015
E-MAIL upen.shah@zyduscadila.com WEB www.zyduscadila.com
TELEPHONE (079) 2686 8326 FAX (079) 2686 2365
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Sharepro Serv.,416-420, Devnandan Mall, Ellisbridge, Ahmedabad-09
AUDITOR Mukesh M. Shah & Co.
CHM: Pankaj R. Patel (MD) COMP SEC: Upen H. Shah YEAR OF INC: 1995 BSE CODE: 532321 FV (Rs): 5 DIV YIELD (%): 0.9

Read: CADILA HEALTHCARE 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   GSK PHARMA  FRESENIUS KABI ONCO.  AMAR REMEDIES  MERCK LTD  FDC LTD.  

Compare CADILA HEALTHCARE With:   GSK PHARMA  FRESENIUS KABI ONCO.  AMAR REMEDIES  MERCK LTD  FDC LTD.  

Compare CADILA HEALTHCARE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 297 Points Higher; Energy and Realty Stocks Witness Buying(Closing)

Share markets in India continued their momentum during closing hours and ended the day on a positive note. Sectoral indices were trading on a positive note, with stocks in the energy sector.

Views on news

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Up 274.4% (Quarterly Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

For the quarter ended June 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (up 274.4% YoY). Sales on the other hand came in at Rs 29 bn (up 29.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 50.4% (Quarterly Result Update)

May 28, 2018 | Updated on May 28, 2018

For the quarter ended March 2018, CADILA HEALTHCARE has posted a net profit of Rs 6 bn (up 50.4% YoY). Sales on the other hand came in at Rs 33 bn (up 28.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Don't Panic in This Falling Market... Do This Instead(The 5 Minute Wrapup)

Oct 5, 2018

Find companies with long term durable moats, which are correcting with the current broader market sell-off.

Why You Should Be Excited, Not Sad, About the 30% Small Cap Crash(Profit Hunter)

Oct 4, 2018

Smallcaps have corrected over 30% since the beginning of the year. Find out why Richa Agarwal views this as an opportunity rather than a threat.

Taxpayers to pay salaries of CEOs/CIOs of Mutual Funds(The Honest Truth)

Oct 5, 2018

Ajit Dayal on the crisis in the market and in the mutual fund industry.

Why Are Investors In Sundaram Small Cap Fund Anxious(Outside View)

Oct 3, 2018

A small cap fund that aims to capitalise on emerging businesses and catch them young. However, its failure in keeping volatility under check is making its investors anxious.

Biggest Corrections in the Stock of Infibeam Avenues(Chart Of The Day)

Oct 3, 2018

Infibeam plunged over 70% last week. This was the second biggest single-day fall. But Infibeam witnessed such sharp falls earlier.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - TEVA PHARMA COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS